UnitedHealth Group Incorporated
- Open
- 419.93
- Day high
- 426.76
- Day low
- 415.11
- Prev close
- 417.64
- Volume
- 1.6M
- Mkt cap
- $387.0B
- P/E (TTM)
- 27.4
- EPS (TTM)
- $15.55
- P/B
- 3.7
- P/S
- 0.9
- Yield
- 1.06%
- Per share
- $4.53
UnitedHealth Group Incorporated (UNH) is a Healthcare company listed on NYSE. The stock is up 48% over the past year. Drillr has 2 published research articles covering UNH.
UnitedHealth Group Incorporated (UNH) financials & analyst ratings
Fundamentals (TTM)
Analyst consensus · 16 analysts
Source: exchange market data + company filings. Figures are trailing-twelve-month or as most recently reported. For informational purposes only — not investment advice.
UNH earnings date, history & EPS estimates
| Report date | EPS est | EPS actual | Surprise | Revenue | Rev. surprise |
|---|---|---|---|---|---|
| Jul 16, 2026 | $4.94 | $6.38 | +29.1% | $112.0B | +1.1% |
| Apr 21, 2026 | $6.58 | $7.23 | +9.9% | $111.7B | +2.1% |
| Jan 27, 2026 | $2.10 | $2.11 | +0.5% | $113.2B | -0.5% |
| Apr 17, 2025 | $7.29 | $7.20 | -1.2% | $109.6B | -1.8% |
| Jan 16, 2025 | $6.74 | $6.81 | +1.0% | $100.8B | -0.8% |
| Oct 15, 2024 | $7.00 | $7.15 | +2.1% | $99.2B | +0.0% |
| Jul 16, 2024 | $6.65 | $6.80 | +2.3% | $97.9B | -0.9% |
| Apr 16, 2024 | $6.61 | $6.91 | +4.5% | $98.8B | -0.5% |
| Jan 12, 2024 | $5.98 | $6.16 | +3.0% | $93.2B | +1.2% |
| Oct 13, 2023 | $6.32 | $6.56 | +3.8% | $91.4B | +5.5% |
| Jul 14, 2023 | $5.99 | $6.14 | +2.5% | $91.8B | +10.7% |
| Apr 14, 2023 | $6.13 | $6.26 | +2.1% | $91.9B | +2.4% |
UNH insider trading activity (SEC Form 4)
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Jul 6, 2026 | FLYNN TIMOTHY PATRICKdirector | Grant | 225 | — |
| Jul 6, 2026 | MCNABB FREDERICK WILLIAM IIIdirector | Grant | 250 | — |
| Jul 6, 2026 | Gottlieb Scottdirector | Grant | 210 | — |
| Jul 6, 2026 | Gil Kristendirector | Grant | 206 | — |
| Jul 6, 2026 | GARCIA PAUL Rdirector | Grant | 88 | — |
| Jul 6, 2026 | Noseworthy John Hdirector | Grant | 206 | — |
| Jul 6, 2026 | MONTGOMERY RICE VALERIE MDdirector | Grant | 220 | — |
| Jul 6, 2026 | GARCIA PAUL Rdirector | Grant | 132 | — |
| Jul 6, 2026 | Baker Charles D.director | Grant | 220 | — |
| Jun 25, 2026 | Gil Kristendirector | Grant | 8 | — |
| Jun 25, 2026 | Conway Patrick Hughofficer: Chief Executive Officer, Optum | Grant | 82 | — |
| Jun 25, 2026 | FLYNN TIMOTHY PATRICKdirector | Grant | 61 | — |
| Jun 25, 2026 | DeVeydt Wayne Sofficer: Chief Financial Officer | Grant | 112 | — |
| Jun 25, 2026 | MCNABB FREDERICK WILLIAM IIIdirector | Grant | 50 | — |
| Jun 25, 2026 | Gottlieb Scottdirector | Grant | 3 | — |
Source: UNH SEC Form 4 filings, latest Jul 6, 2026. For informational purposes only — not investment advice.
See the full UNH insider & 13F page →UNH research & analysis
Medicare Advantage 2026 Rate Hike: UNH and HUM Lead Margin Winners — Ranked
The April 7, 2026, Medicare Advantage rate decision sparked gains for UNH and HUM, signaling margin relief for exposed insurers. UNH leads with balanced exposure and scale, followed by HUM's pure-play bet and CI's value. Rankings prioritize MA leverage, growth, and valuations amid stabilizing reimbursements.
HUMCICVSIf CMS finalizes the 6.4% home health payment cut, which operators face the steepest margin compression?
Among publicly traded operators, Aveanna Healthcare (AVAH) faces the steepest margin compression from a potential 6.4% CMS home health payment cut, given its leveraged balance sheet (5.1x debt/EBITDA) and thin free cash flow ($26M), despite home health representing only ~10% of revenue. Ensign Group has minimal direct exposure as a SNF-focused operator, while Sotera Health has no home health revenue and Amedisys was acquired by UnitedHealth in 2024.
AVAHENSGSHC
UnitedHealth Group Incorporated company profile
Overview
UnitedHealth Group Incorporated (NYSE:UNH) is a diversified healthcare company founded in 1977 and incorporated in Minnesota. What began as a small health maintenance organization has grown into the largest healthcare company in the United States by revenue. The company went public in 1984 and has since expanded through organic growth and strategic acquisitions to become a dominant force across multiple segments of the healthcare ecosystem. Today, UnitedHealth Group operates as both a health insurance provider and a comprehensive healthcare services company, serving millions of Americans through its integrated platform of insurance coverage, healthcare delivery, pharmacy services, and health technology solutions.
Business
UnitedHealth Group operates in the complex U.S. healthcare industry through four main business segments that work together to provide comprehensive healthcare solutions. The company essentially functions as both a health insurance payer and a healthcare services provider, creating an integrated ecosystem. UnitedHealthcare represents the traditional health insurance business, generating approximately 75% of total company revenue at around $300 billion annually. This segment provides health benefit plans to various customer groups including large national employers, government entities, small businesses, and individual consumers. The division offers Medicare Advantage plans for seniors, Medicaid managed care for low-income populations, and commercial insurance for working-age Americans. Medicare Advantage, where UnitedHealth acts as a private insurer administering Medicare benefits, represents a particularly significant growth area. Optum Health operates the company's healthcare delivery and value-based care services, generating roughly 25% of revenue at approximately $105-117 billion. This segment includes networks of physicians, clinics, and care centers that directly provide medical services to patients. The division focuses on "value-based care" arrangements where providers are paid based on patient health outcomes rather than the volume of services provided. This includes managing care for millions of patients with chronic conditions like diabetes and heart disease. Optum Rx functions as a pharmacy benefit manager (PBM), handling prescription drug benefits for health plans and generating about 32% of revenue at roughly $130-146 billion. PBMs negotiate drug prices with pharmaceutical companies, manage pharmacy networks, and process prescription claims. This segment also operates specialty pharmacies that handle complex medications for conditions like cancer and rare diseases. Optum Insight provides healthcare technology, data analytics, and consulting services, representing the smallest segment at approximately $19-22 billion in revenue. This division offers software solutions to hospitals and health systems, conducts data analysis to improve healthcare outcomes, and provides consulting services to help healthcare organizations operate more efficiently.
Revenue model
UnitedHealth Group generates revenue through multiple complementary business models that create a diversified income stream. The primary revenue source comes from insurance premiums collected from UnitedHealthcare's health plans, where members pay monthly premiums for coverage and the company assumes the financial risk of their medical expenses. This traditional insurance model generates the majority of the company's $400+ billion in annual revenue. The company also earns revenue through service fees from its Optum divisions. Optum Health collects payments for medical services provided at its clinics and through its physician networks, operating similarly to a traditional healthcare provider. Optum Rx generates revenue by charging fees for processing prescription claims, negotiating rebates from drug manufacturers, and earning margins on pharmaceutical sales. Optum Insight operates on a subscription and consulting model, charging healthcare organizations for software licenses, data analytics services, and advisory consulting. Several factors significantly impact the company's profitability margins. Medical cost trends represent the largest variable, as rising healthcare utilization or more expensive treatments directly reduce insurance margins. The company's medical loss ratio - the percentage of premiums paid out as medical claims - typically runs around 82-86% for Medicare Advantage plans. Government reimbursement rates heavily influence profitability, particularly Medicare Advantage funding from the Centers for Medicare & Medicaid Services (CMS), which has faced recent cuts. Pharmaceutical pricing affects both insurance costs and PBM margins, while regulatory changes around healthcare policy can dramatically impact business operations. Competition from other insurers and new market entrants pressures premium pricing, while the company's scale and integrated model provide cost advantages through care coordination and administrative efficiencies.
Competitive moat
UnitedHealth Group possesses several significant competitive advantages that create substantial barriers to entry. The company's primary moat stems from its massive scale and integrated ecosystem. With over 50 million health plan members, UnitedHealth achieves economies of scale that smaller competitors cannot match, allowing for lower administrative costs per member and greater negotiating power with healthcare providers and pharmaceutical companies. The company's data advantage represents another formidable moat. Processing billions of healthcare transactions annually provides UnitedHealth with unparalleled insights into healthcare utilization patterns, cost trends, and clinical outcomes. This data enables more accurate risk assessment for insurance pricing and more effective care management programs. The integration between insurance, provider networks, and pharmacy services creates powerful network effects where each business segment strengthens the others. Regulatory barriers also protect the company's position, as health insurance requires significant capital reserves, state licensing, and complex compliance capabilities that deter new entrants. The Medicare Advantage business particularly benefits from regulatory complexity and established relationships with CMS. However, the moat faces several potential threats. Government policy changes represent the most significant risk, as Medicare for All or other single-payer proposals could eliminate private insurance markets. Technology disruption from companies like Amazon, which has entered healthcare services, could challenge traditional models. Antitrust scrutiny has intensified as UnitedHealth's market dominance grows, potentially limiting future acquisitions or forcing divestitures. The company's vertical integration, while providing advantages, also creates regulatory risks around conflicts of interest between its insurance and provider businesses. Despite these challenges, UnitedHealth's scale, data assets, and integrated platform create a strong competitive position that would be extremely difficult for new entrants to replicate.
Risks & safety
UnitedHealth Group demonstrates a strong financial position with adequate margin of safety, though some metrics warrant attention. • Liquidity and Solvency: The company maintains $25-30 billion in cash and short-term investments with strong operating cash flow generation of $24-29 billion annually. However, the current ratio of 0.83 indicates current liabilities exceed current assets, typical for insurance companies due to medical claims reserves. • Debt Management: Debt-to-equity ratio of approximately 0.83-0.86 represents moderate leverage levels. The company generates sufficient cash flow to service debt obligations comfortably. • Valuation Metrics: Trading at P/E ratios of 19-27x recent earnings with EV/EBITDA multiples ranging from 13-28x depending on the quarter. Price-to-book ratios around 5.0-5.7x reflect premium valuation typical of quality healthcare companies. • Operational Considerations: Medical loss ratios have shown some pressure, particularly in Medicare Advantage, requiring careful monitoring. The company faces ongoing regulatory risks from potential healthcare reform and antitrust scrutiny.
Recent development
Over the past few years, UnitedHealth Group has pursued several key strategic initiatives focused on expanding its integrated healthcare platform and leveraging technology for competitive advantage. The company has significantly invested in artificial intelligence and digital transformation, implementing AI across hundreds of use cases to improve operational efficiency, with some applications showing 20% productivity gains. Digital engagement among members has increased substantially, with mobile app usage growing 66% year-over-year. The company has aggressively expanded its value-based care footprint through Optum Health, growing from serving 3.2 million patients in value-based arrangements to over 5.4 million, with plans to add 650,000 more patients annually. This includes expanding home-based care services and community health centers to over 750 locations. UnitedHealth has also committed to achieving 100% rebate pass-through by 2028 in response to pharmacy benefit manager reform discussions, demonstrating proactive adaptation to regulatory pressures. The company has navigated significant external challenges including recovering from the Change Healthcare cyberattack that disrupted operations and cost $0.60-0.70 per share in 2024. Management has also adapted to CMS Medicare funding cuts and the transition to new risk adjustment models (V28), which proved more complex than anticipated. In response, the company has enhanced care management programs, improved patient engagement strategies, and adjusted Medicare Advantage plan designs for future years. Recent quarters have shown some operational challenges with elevated care utilization in Medicare Advantage, prompting increased focus on clinical program engagement and home-based services to better manage member health outcomes.
UNH company profile · for informational purposes only — not investment advice.
Track UNH with Drillr
SEC filings, earnings calls, insider activity, alt-data signals — all queryable through Drillr's AI terminal and MCP API.
Try Drillr for free